These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38843940)

  • 1. Challenges to the optimisation of cystic fibrosis exacerbation treatment outcomes.
    Goss CH; VanDevanter DR
    Eur Respir J; 2024 Jun; 63(6):. PubMed ID: 38843940
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Perry LA; Penny-Dimri JC; Aslam AA; Lee TW; Southern KW
    Paediatr Respir Rev; 2017 Mar; 22():47-49. PubMed ID: 27964951
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges facing microRNA therapeutics for cystic fibrosis lung disease.
    De Santi C; Greene CM
    Epigenomics; 2020 Feb; 12(3):179-181. PubMed ID: 32011168
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis and Management of Cystic Fibrosis Exacerbations.
    Milinic T; McElvaney OJ; Goss CH
    Semin Respir Crit Care Med; 2023 Apr; 44(2):225-241. PubMed ID: 36746183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee TW; Southern KW; Perry LA; Penny-Dimri JC; Aslam AA
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005599. PubMed ID: 27314455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Fetal Cystic Fibrosis With Cystic Fibrosis Transmembrane Conductance Regulator Modulation Therapy.
    Blumenfeld YJ; Hintz SR; Aziz N; Barth RA; Spano JM; El-Sayed YY; Milla C
    Ann Intern Med; 2023 Jul; 176(7):1015-1016. PubMed ID: 37307583
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel, mechanism-based therapies for cystic fibrosis.
    Rubenstein RC
    Curr Opin Pediatr; 2005 Jun; 17(3):385-92. PubMed ID: 15891431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protein repair therapy in cystic fibrosis].
    Clément A; Tamalet A; Fauroux B; Epaud R
    Rev Prat; 2003 Jan; 53(2):163-6. PubMed ID: 12664848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapies in cystic fibrosis.
    Ratjen F; Grasemann H
    Curr Pharm Des; 2012; 18(5):614-27. PubMed ID: 22229570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strategies for gene therapy in cystic fibrosis].
    Bargon J; Buhl R
    Pneumologie; 1996 Aug; 50(8):562-8. PubMed ID: 8975248
    [No Abstract]   [Full Text] [Related]  

  • 11. Current progress in cystic fibrosis: is this a disease elusive to therapy?
    Brown C
    Pulm Pharmacol Ther; 2008 Aug; 21(4):585-7. PubMed ID: 18313958
    [No Abstract]   [Full Text] [Related]  

  • 12. Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators.
    Konrad J; Eber E; Stadlbauer V
    Paediatr Respir Rev; 2022 Jun; 42():9-16. PubMed ID: 33485777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Challenges of personalized medicine for cystic fibrosis].
    Corvol H; Taytard J; Tabary O; Le Rouzic P; Guillot L; Clement A
    Arch Pediatr; 2015 Jul; 22(7):778-86. PubMed ID: 26021452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status of gene therapy for cystic fibrosis lung disease.
    Boucher RC
    J Clin Invest; 1999 Feb; 103(4):441-5. PubMed ID: 10021450
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy for cystic fibrosis: which postman, which box?
    Middleton PG; Alton EW
    Thorax; 1998 Mar; 53(3):197-9. PubMed ID: 9659356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy in cystic fibrosis.
    Armstrong DK; Cunningham S; Davies JC; Alton EW
    Arch Dis Child; 2014 May; 99(5):465-8. PubMed ID: 24464978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for gene therapy for cystic fibrosis.
    Davies JC; Geddes DM; Alton EW
    Mol Med Today; 1998 Jul; 4(7):292-9. PubMed ID: 9743990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
    Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
    Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
    [No Abstract]   [Full Text] [Related]  

  • 19. [New therapeutic approaches in cystic fibrosis].
    Vestner A; Schrepfer B; Kockler J; Mohr F; Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2008; 37(5):354-5. PubMed ID: 18729285
    [No Abstract]   [Full Text] [Related]  

  • 20. Cystic fibrosis: evolution from a fatal disease of infancy with a clear phenotype to a chronic disease of adulthood with diverse manifestations.
    Ren CL
    Clin Rev Allergy Immunol; 2008 Dec; 35(3):97-9. PubMed ID: 18496774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.